Guided Therapeutics (GTHP) Current Assets (2010 - 2026)
Guided Therapeutics (GTHP) posted Current Assets of $605000.0 for Q4 2025, down 24.28% sequentially from $799000.0 in Q3 2025, and down 49.46% YoY from $1.2 million in Q4 2024.
Guided Therapeutics (GTHP) Current Assets (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Current Assets for 16 years, with the latest figure at $605000.0 in Q4 2025.
- Quarterly Current Assets fell 49.46% year-over-year to $605000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $605000.0 (down 49.46% YoY) and the FY2025 annual result came in at $605000.0, down 49.46% from the prior year.
- Current Assets fell to $605000.0 in Q4 2025 per GTHP's latest filing, from $799000.0 in the prior quarter.
- Over five years, Current Assets peaked at $3.5 million in Q3 2022 and troughed at $605000.0 in Q4 2025.
- A 5-year average of $1.5 million and a median of $1.4 million in 2021 frame the typical range for Current Assets.
- The sharpest annual moves came in 2021 and 2023: Current Assets surged 705.04% in 2021, then plunged 54.8% in 2023.
- Over 5 years, Current Assets stood at $1.6 million in 2021, then soared by 83.51% to $3.0 million in 2022, then sank by 53.63% to $1.4 million in 2023, then fell by 14.07% to $1.2 million in 2024, then tumbled by 49.46% to $605000.0 in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $605000.0, $799000.0, and $811000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.42 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 7.97 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 6.82 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 4.09 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.50 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.84 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | 527,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 527,000.00 |
| Dec 31, 2025 | 605,000.00 |
| Sep 30, 2025 | 799,000.00 |
| Jun 30, 2025 | 811,000.00 |
| Mar 31, 2025 | 811,000.00 |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.39 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 2.03 Mn |
| Mar 31, 2023 | 2.55 Mn |
| Dec 31, 2022 | 3.00 Mn |
| Sep 30, 2022 | 3.49 Mn |
| Jun 30, 2022 | 1.10 Mn |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | 1.64 Mn |
| Sep 30, 2021 | 1.33 Mn |
| Jun 30, 2021 | 1.64 Mn |